CY1857A - 1-indolylalkyl-4-(alkoxy-pyrimidinyl)piperazines - Google Patents

1-indolylalkyl-4-(alkoxy-pyrimidinyl)piperazines

Info

Publication number
CY1857A
CY1857A CY185796A CY185796A CY1857A CY 1857 A CY1857 A CY 1857A CY 185796 A CY185796 A CY 185796A CY 185796 A CY185796 A CY 185796A CY 1857 A CY1857 A CY 1857A
Authority
CY
Cyprus
Prior art keywords
alkoxy
lower alkyl
indolylalkyl
piperazines
hydrogen
Prior art date
Application number
CY185796A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of CY1857A publication Critical patent/CY1857A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03B—APPARATUS OR ARRANGEMENTS FOR TAKING PHOTOGRAPHS OR FOR PROJECTING OR VIEWING THEM; APPARATUS OR ARRANGEMENTS EMPLOYING ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ACCESSORIES THEREFOR
    • G03B7/00—Control of exposure by setting shutters, diaphragms or filters, separately or conjointly
    • G03B7/08—Control effected solely on the basis of the response, to the intensity of the light received by the camera, of a built-in light-sensitive device
    • G03B7/099—Arrangement of photoelectric elements in or on the camera
    • G03B7/0993—Arrangement of photoelectric elements in or on the camera in the camera
    • G03B7/0997—Through the lens [TTL] measuring
    • G03B7/09971—Through the lens [TTL] measuring in mirror-reflex cameras
    • G03B7/09976—Through the lens [TTL] measuring in mirror-reflex cameras the sensor being mounted in, before, or behind the porro-prism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
CY185796A 1990-06-29 1996-04-05 1-indolylalkyl-4-(alkoxy-pyrimidinyl)piperazines CY1857A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/546,121 US5077293A (en) 1990-06-29 1990-06-29 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines

Publications (1)

Publication Number Publication Date
CY1857A true CY1857A (en) 1996-04-05

Family

ID=24178969

Family Applications (1)

Application Number Title Priority Date Filing Date
CY185796A CY1857A (en) 1990-06-29 1996-04-05 1-indolylalkyl-4-(alkoxy-pyrimidinyl)piperazines

Country Status (19)

Country Link
US (1) US5077293A (fr)
EP (1) EP0464604B1 (fr)
JP (1) JPH0819123B2 (fr)
KR (1) KR920000749A (fr)
AT (1) ATE120462T1 (fr)
AU (1) AU643765B2 (fr)
CA (1) CA2045359C (fr)
CY (1) CY1857A (fr)
DE (1) DE69108461T2 (fr)
DK (1) DK0464604T3 (fr)
ES (1) ES2071169T3 (fr)
FI (1) FI100241B (fr)
GR (1) GR3015585T3 (fr)
HK (1) HK109695A (fr)
IE (1) IE67288B1 (fr)
MX (1) MX9202844A (fr)
PT (1) PT98114B (fr)
TW (1) TW198030B (fr)
ZA (1) ZA915036B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2043709C (fr) * 1990-06-29 2002-01-22 David W. Smith Derives pour combattre la migraine d'alcoxypirimidine
FR2673628B1 (fr) * 1991-03-07 1993-07-09 Esteve Labor Dr Procede de preparation de derives d'aryl (ou heteroaryl)-piperazinyl-butyl-azoles.
CA2084531A1 (fr) * 1991-12-19 1993-06-20 David W. Smith Derives antimigraines 4-pyrimidinyle et pyridinyle d'indol-3yl-alkylpiperazines
CA2130078A1 (fr) * 1993-09-16 1995-03-17 Jonas A. Gylys Derives cyclobutenediones de l'indolylakylpyridinyle et des pyrimidinylpiperazines ayant des proprietes antimigraineuses
US5521188A (en) * 1993-09-16 1996-05-28 Bristol-Myers Squibb Company Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines
CN1166169A (zh) * 1994-07-27 1997-11-26 三共株式会社 用作毒蕈碱性受体别构效应物的杂环化合物
GB9423682D0 (en) * 1994-11-23 1995-01-11 Merck Sharp & Dohme Therapeutic agents
GB9501865D0 (en) * 1995-01-31 1995-03-22 Merck Sharp & Dohme Therapeutic agents
US5618816A (en) * 1995-03-02 1997-04-08 Bristol-Myers Squibb Company Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridnyl and pyrimidinylpiperazines
JPH09124643A (ja) * 1995-08-14 1997-05-13 Bristol Myers Squibb Co 抗うつ作用を有する１−アリールアルキル−４−（アルコキシピリジニル）−又は４−（アルコキシピリミジニル）ピペラジン誘導体
JP4076234B2 (ja) * 1996-06-28 2008-04-16 明治製菓株式会社 テトラヒドロベンズインドール化合物
SE9603283D0 (sv) * 1996-09-10 1996-09-10 Astra Ab New compounds
TW472045B (en) 1996-09-25 2002-01-11 Astra Ab Protein kinase C inhibitor compounds, method for their preparation, pharmaceutical composition thereof and intermediate used for their preparation
AR017200A1 (es) 1997-12-23 2001-08-22 Astrazeneca Ab Compuestos inhibidores de la proteina cinasa c, sales farmaceuticamente aceptables de los mismos, formulaciones farmaceuitcas que los comprenden, usode las mismas y proceso para la sintesis de dichos compuestos
SE9800835D0 (sv) 1998-03-13 1998-03-13 Astra Ab New Compounds
US6492406B1 (en) 1999-05-21 2002-12-10 Astrazeneca Ab Pharmaceutically active compounds
US6346625B1 (en) 1999-06-23 2002-02-12 Astrazeneca Ab Protein kinase inhibitors
GB0119797D0 (en) 2001-08-14 2001-10-03 Glaxo Group Ltd Chemical compounds
US20040023977A1 (en) * 2002-07-15 2004-02-05 Larsen Robert D. Process for making substituted thiazolyl-amino pyrimidinyl
DE10252102A1 (de) * 2002-11-08 2004-05-27 Merck Patent Gmbh Indolderivate
WO2010075273A1 (fr) 2008-12-23 2010-07-01 Schering Corporation Dérivés d'hétérocycles bicycliques et leurs procédés d'utilisation
EP3027607B1 (fr) * 2013-07-29 2020-08-26 Sunshine Lake Pharma Co., Ltd. Composés hétéroaryliques substitués et procédés d'utilisation
US10316025B2 (en) 2015-06-03 2019-06-11 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use and use thereof
US11285153B2 (en) 2017-09-29 2022-03-29 Sunshine Lake Pharma Co., Ltd. Substituted pyrimidine piperazine compound and use thereof
CN108658871B (zh) * 2018-06-19 2020-10-30 舞阳威森生物医药有限公司 周效磺胺中间体4,6-二氯-5-甲氧基嘧啶的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB944443A (fr) * 1959-09-25 1900-01-01
GB1189064A (en) * 1967-05-01 1970-04-22 Sterling Drug Inc Indole Derivatives
GR79215B (fr) * 1982-06-07 1984-10-22 Glaxo Group Ltd
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
US4954502A (en) * 1988-06-10 1990-09-04 Bristol-Myers Squibb Company 1-indolyalkyl-4-(substituted-pyridinyl)piperazines
FR2635104B1 (fr) * 1988-08-03 1992-04-30 Synthelabo Derives d'indolone, leur preparation et leur application en therapeutique
CA2043709C (fr) * 1990-06-29 2002-01-22 David W. Smith Derives pour combattre la migraine d'alcoxypirimidine

Also Published As

Publication number Publication date
TW198030B (fr) 1993-01-11
AU643765B2 (en) 1993-11-25
FI913117A (fi) 1991-12-30
AU7403791A (en) 1992-01-02
JPH04230377A (ja) 1992-08-19
US5077293A (en) 1991-12-31
MX9202844A (es) 1992-06-30
JPH0819123B2 (ja) 1996-02-28
EP0464604B1 (fr) 1995-03-29
DE69108461D1 (de) 1995-05-04
IE912279A1 (en) 1992-01-01
EP0464604A2 (fr) 1992-01-08
ZA915036B (en) 1993-02-24
ATE120462T1 (de) 1995-04-15
PT98114B (pt) 1998-12-31
FI100241B (fi) 1997-10-31
CA2045359A1 (fr) 1991-12-30
ES2071169T3 (es) 1995-06-16
IE67288B1 (en) 1996-03-20
GR3015585T3 (en) 1995-06-30
FI913117A0 (fi) 1991-06-26
EP0464604A3 (en) 1992-02-26
DK0464604T3 (da) 1995-06-12
DE69108461T2 (de) 1995-07-27
PT98114A (pt) 1992-03-31
HK109695A (en) 1995-07-14
CA2045359C (fr) 2001-09-04
KR920000749A (ko) 1992-01-29

Similar Documents

Publication Publication Date Title
TW198030B (fr)
CY1846A (en) 1-Indolylalkyl-4-(substituted-pyridinyl) piperazines
EP1035123A4 (fr) Nouveaux composes heterocycliques
GB2218988B (en) Aryl-and heteroaryl piperazinyl carboxamides having central nervous system activity
EP0256503A3 (en) Pyridinecarboxamide derivatives and their use as fungicide
PE34996A1 (es) Nuevo derivado de pirrocarbazol
ES2068413T3 (es) Derivados de 4-fenilftalazina.
TW275629B (fr)
ATE151987T1 (de) Verwendung von 3-pyridazinone zur verringerung der blutplätchenzahl
EP0443474A3 (en) 1-phenoxycarbonyl-2-pyrrolidinone derivatives and nootropic agents
GR3004321T3 (fr)
EP0919233A4 (fr) Agent therapeutique contre les maladies renales
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.